"dancing eye syndrome" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer

23Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Among paraneoplastic neurologic disorders (PND), opsoclonus-myoclonus syndrome, so-called "dancing eye syndrome," is a rare disorder combining multivectorial eye movements, involuntary multifocal myoclonus, and cerebellar ataxia. Although several paraneoplastic antibodies against postsynaptic or cell-surface antigens have been reported, usually most patients are serum antibody negative. We report a 65-year-old patient with opsoclonus-myoclonus syndrome revealing a small-cell lung carcinoma. If serologic antineuronal anti-body screening was negative, autoantibodies against glutamic acid decarboxylase (anti-GAD) were positive. Despite the specific anticancer treatment and high dose corticosteroids, the patient developed a severe and progressive encephalopathy and died 10 days later. © 2014 S. Laroumagne et al.

Cite

CITATION STYLE

APA

Laroumagne, S., Elharrar, X., Coiffard, B., Plojoux, J., Dutau, H., Breen, D., & Astoul, P. (2014). “dancing eye syndrome” secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer. Case Reports in Medicine, 2014. https://doi.org/10.1155/2014/545490

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free